ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 69 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 4.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $31,000 | +34.8% | 86,824 | +64.6% | 0.00% | 0.0% |
| Q1 2017 | $23,000 | -20.7% | 52,746 | -10.2% | 0.00% | 0.0% |
| Q4 2016 | $29,000 | +70.6% | 58,727 | +250.9% | 0.00% | – |
| Q2 2016 | $17,000 | -29.2% | 16,738 | -17.1% | 0.00% | – |
| Q4 2015 | $24,000 | -59.3% | 20,198 | -24.2% | 0.00% | -100.0% |
| Q3 2015 | $59,000 | -75.8% | 26,634 | -74.5% | 0.00% | -75.0% |
| Q2 2015 | $244,000 | +101.7% | 104,608 | +85.2% | 0.00% | +100.0% |
| Q1 2015 | $121,000 | +157.4% | 56,485 | +172.3% | 0.00% | +100.0% |
| Q4 2014 | $47,000 | +42.4% | 20,740 | +64.2% | 0.00% | 0.0% |
| Q3 2014 | $33,000 | -60.7% | 12,634 | -44.5% | 0.00% | 0.0% |
| Q2 2014 | $84,000 | – | 22,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 396,104 | $400,000 | 0.42% |
| Ancora Advisors LLC | 50,865 | $51,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 145,710 | $146,000 | 0.00% |
| Acrospire Investment Management LLC | 5,200 | $5,000 | 0.00% |
| A.R.T. Advisors, LLC | 57,954 | $57,000 | 0.00% |
| Renaissance Technologies | 876,100 | $876,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 4,600 | $5,000 | 0.00% |
| Cutler Group LLC / CA | 11,048 | $11,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 133,846 | $134,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $46,000 | 0.00% |